FDA recall, , Low risk
Carter BloodCare Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced were leukoreduced by filtration at an unacceptable temperature.
Recall ended Sep 22, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
Carter BloodCare began a recall of Red Blood Cells, Leukocytes Reduced on June 16, 2025, because the product was leukoreduced by filtration at an unacceptable temperature. The recall was added to the FDA's Enforcement Report on September 22, 2026, and distributed in Texas.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- Carter BloodCare
- Hazard
- Processing problem
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 99581
- Recall number
- B-0264-2026
All recalls from Carter BloodCare
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
